ID   DND-10B
AC   CVCL_E994
SY   DND
DR   Cosmic; 733813
DR   IARC_TP53; 23622
DR   Wikidata; Q54831318
RX   CelloPub=CLPUB00035;
RX   PubMed=1568228;
RX   PubMed=3334988;
CC   Doubling time: 48 hours (CelloPub=CLPUB00035).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=3334988;
RA   Popescu, Nicholas Constantin
RA   Chahinian, A. Philippe
RA   DiPaolo, Joseph A.
RT   "Nonrandom chromosome alterations in human malignant mesothelioma.";
RL   Cancer Res. 48:142-147(1988).
//
RX   PubMed=1568228;
RA   Metcalf, Robert A.
RA   Welsh, Judith A.
RA   Bennett, William P.
RA   Seddon, Michael B.
RA   Lehman, Teresa A.
RA   Pelin-Enlund, Katarina
RA   Linnainmaa, Kaija
RA   Tammilehto, Lauri
RA   Mattson, Karin
RA   Gerwin, Brenda Isen
RA   Harris, Curtis Craig
RT   "p53 and Kirsten-ras mutations in human mesothelioma cell lines.";
RL   Cancer Res. 52:2610-2615(1992).
//
RX   CelloPub=CLPUB00035;
RA   Ohnuma, Takao
RA   Wolman, Sandra R.
RA   Daum, Susan M.
RA   Holland, James Frederick
RT   "Establishment and characterization of a human mesothelioma cell
RT   line.";
RL   Proc. Am. Assoc. Cancer Res. 20:162.653-162.653(1979).
//